Table 2.
Summary of single arm studies in EUS-biliary drainage
| Author | Study design | Patients (n) | Pathology | Intervention | Overall technical success rate, % (n) | Overall Clinical Success Rate, %(n) | Overall Adverse Events, %(n) | Stent Migration %(n) |
|---|---|---|---|---|---|---|---|---|
| Hara et al. (2011)[21] | Prospective, Single Center | 18 | MDBO | EUS-CDS | 94 (17/18) | 100 (17/17) | 17 (3/18) | 5.6 (1/18) |
| Song et al. (2012)[20] | Retrospective, Single Center | 15 | MDBO | EUS-CDS | 86.7 (13/15) | 100 (13/13) | 23.1 (3/13) | 30.8 (4/13) |
| Kunda et al. (2016)[22] | Retrospective, Multicenter | 57 | MDBO | EUS CDS | 98.2 (56/57) | 94.7 (54/57) | 9 (7/57) | 1.7 (1/57) |
| Ogura et al. (2016)[27] | Retrospective, single center | 10 | MHBO | EUS-HGS | 100 (10/10) | 90 (9/10) | 0 | NA |
| Lu et al. (2017)[23] | Retrospective, single center | 24 | MBO | 17 EUS-CDS 4 EUS-HGS | 95.8 (23/24) | 100 (23/23) | 13 (3/23) | 0 |
| Minaga et al. (2017)[25] | Retrospective, single center | 30 | MHBO | EUS-HGS | 96.7 (29/30) | 75.9 (22/29) | 10 (3/30) | 0 |
| Moryouseff et al. (2017)[26] | Prospective, single center | 18 | MHBO | EUS-HGS | 94 (17/18) | 72.2 (13/17) | 16.7 (3/18) | 0 |
MHBO: Malignant hilar biliary obstruction; NA: Not available; MBO: Malignant biliary obstruction; CDS: Choledochoduodenostomy; HGS: Hepaticogastrostomy